Dr. Daniel Wei Lin, MD

Dr. Lin practices at UW Medical Center - Montlake in Seattle, Washington, part of University of Washington.

Dr. Lin's NPI, 1548356306, was assigned on October 5, 2006. Dr. Lin graduated from Vanderbilt University School of Medicine in 1994. Dr. Lin holds Washington license MD00035500.

Dr. Lin's primary practice is UW Medical Center - Montlake, at 1959 NE Pacific St Box 356151, Seattle, WA 98195 in King County. The practice phone is (206) 598-3300.

Dr. Lin's primary practice is UW Medical Center - Montlake in Seattle, Washington, part of University of Washington. Dr. Lin is also affiliated with Fred Hutchinson Cancer Center. The medical group on file is UW Physicians. Dmand AI also links Dr. Lin to 3 more hospitals, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Lin is licensed in Washington.

CMS data shows 550 Medicare services from Dr. Lin across 11 procedure codes in 2024, for 351 Medicare patients. Medicare paid $53,647 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 351 Medicare patients who saw Dr. Lin in 2024. The largest group is 65 to 74, with 211 patients. 75% of them have cancer, and 67% have high cholesterol. 4% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 69, with 7% women.

In 2024, Dr. Lin wrote 217 Medicare Part D claims for 86 patients. 99% of them were for generic drugs. CMS names the drug for 198 of them, across 5 drugs with 11 or more claims each, at $3,655 in total drug cost. In 2023, CMS named 158 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Lin for performance year 2024, reported through an alternative payment model (APM). Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lin as offering telehealth. CMS counts 16 procedures of prostate resection by Dr. Lin, more than 74% of the clinicians it reports for that procedure.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 86 general payments to Dr. Lin from 19 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 86% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $14,384. It also lists 9 research payments totaling $5,007 from 2016 to 2023.

Dr. Lin graduated from Vanderbilt University School of Medicine in 1994.